Bristol-Myers Dismissed

The Associated Press reports that the securities class action pending against Bristol-Myers Squibb Co. (NYSE: BMY) in the S.D.N.Y. has been dismissed with prejudice. The case alleged that Bristol-Myers and certain of its officers had made misrepresentations concerning the company’s accounting practices and its investment in ImClone Systems.

Leave a comment

Filed under Motion To Dismiss Monitor

Leave a Reply

Please log in using one of these methods to post your comment: Logo

You are commenting using your account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s